Related Experiment Video
Updated: Feb 28, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.2K
Exploring the Potential of Receptor Silencing in the Tumor Microenvironment by RNA Interference
Karina Mayumi Tani Bezerra de Melo1, Beatriz Mendonça Alves Bandeira1, Pedro Vinícius Silva Novis1
1Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Avenida da Engenharia S/N, Recife 50740-600, Pernambuco, Brazil.
Biomolecules
|February 27, 2026
Summary
RNA interference (RNAi) offers a novel cancer treatment by silencing receptors that promote tumor growth and resistance. This approach modifies the tumor microenvironment, enhancing immune cell activity and improving responses to conventional therapies.
Area of Science:
- Oncology
- Molecular Biology
- Immunotherapy
Background:
- Cancer is a complex disease driven by genetic/epigenetic changes, often leading to treatment resistance.
- Conventional cancer therapies have limitations including side effects and acquired resistance.
- The tumor microenvironment plays a crucial role in cancer progression and immune evasion.
Purpose of the Study:
- To review RNA interference (RNAi)-mediated receptor silencing as a strategy to overcome cancer treatment resistance.
- To explore how RNAi can modify the tumor microenvironment to enhance anti-tumor immunity.
- To assess the potential of targeting multiple receptors simultaneously for improved therapeutic outcomes.
Main Methods:
- Review of studies utilizing RNA interference (RNAi) for gene silencing in cancer.
- Analysis of RNAi targeting of immune checkpoints (PD-1, CTLA-4) to restore T cell function.
- Examination of RNAi targeting of various receptors (GPCRs, growth factor, interleukin receptors) involved in tumor promotion.
- Investigation of advanced delivery systems like nanoparticles and exosomes for RNAi therapy.
Main Results:
- Silencing immune checkpoints (PD-1, CTLA-4) can restore T cell function and enhance adoptive cell therapy efficacy.
- Targeting receptors like CXCR4, CCR5, A2aR, VEGFR, EGFR, and interleukin receptors inhibits tumor growth, angiogenesis, metastasis, and immunosuppression.
- Multi-target RNAi strategies demonstrate superior antitumor effects compared to single-target approaches.
- Advanced delivery systems facilitate effective RNAi delivery within the tumor microenvironment.
Conclusions:
- RNA interference (RNAi) is a promising therapeutic strategy for cancer treatment.
- Modulating the tumor microenvironment via RNAi enhances tumor vulnerability and reduces treatment resistance.
- Targeting multiple receptors with RNAi offers a potent approach to combat cancer progression and improve therapeutic efficacy.
Related Concept Videos
02:15Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
01:22MicroRNAs
24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
01:22MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
01:23RNA Interference
28.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.3K
02:30siRNA - Small Interfering RNAs
18.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
02:30Small interfering RNAs (siRNA)
5.1K
5.1K